Kilitch Drugs to Sell Ethiopian Subsidiary Stake for $14 Million
Kilitch Drugs said it is divesting its entire shareholding in Kilitch Estro Biotech PLC to Ethiopian state-owned HarmeeCare Pharmaceuticals for $14 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.